{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:36:14Z","timestamp":1794281774873,"version":"4.9.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008580","name":"University of Regina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DK073975-17"],"award-info":[{"award-number":["U01-DK073975-17"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK122280"],"award-info":[{"award-number":["R01-DK122280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK142696-01"],"award-info":[{"award-number":["R01-DK142696-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1053\/j.gastro.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:14:21Z","timestamp":1758273261000},"page":"828-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["AGA Clinical Practice Guideline on Management of Gastroparesis"],"prefix":"10.1053","volume":"169","author":[{"given":"Kyle","family":"Staller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry P.","family":"Parkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Leiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Altayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.08.004_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2021.09.064","article-title":"Epidemiology, etiology, and treatment of gastroparesis: real-world evidence from a large US National Claims Database","volume":"162","author":"Ye","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ajg.2013.453","article-title":"A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial","volume":"109","author":"Olausson","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2013.02.001","article-title":"The AGA Institute process for developing clinical practice guidelines part one: grading the evidence","volume":"11","author":"Sultan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S2468-1253(24)00284-X","article-title":"Rome Foundation and international neurogastroenterology and motility societies' consensus on idiopathic gastroparesis","volume":"10","author":"Schol","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MOG.0000000000000978","article-title":"Gastroparesis: time for a paradigm change","volume":"39","author":"Lacy","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2022.12.014","article-title":"Efficacy and safety of drugs for gastroparesis: systematic review and network meta-analysis","volume":"164","author":"Ingrosso","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib7","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.cgh.2022.07.011","article-title":"Epidemiology and healthcare utilization in patients with gastroparesis: a systematic review","volume":"21","author":"Dilmaghani","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.cgh.2024.01.009","article-title":"Burden and treatment of chronic upper gi symptoms and diagnoses: a nationwide study","volume":"22","author":"Sanayei","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1572-0241.2007.01658.x","article-title":"Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004","volume":"103","author":"Wang","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3748\/wjg.v23.i7.1298","article-title":"Psychological controversies in gastroparesis: a systematic review","volume":"23","author":"Woodhouse","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.gastro.2025.08.004_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2982.2012.01879.x","article-title":"Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)","volume":"24","author":"Revicki","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.gastro.2025.08.004_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14960","article-title":"The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD): Psychometric validation and meaningful change threshold in patients with idiopathic or diabetic gastroparesis","volume":"37","author":"Chen","year":"2025","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib15","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.cgh.2024.01.005","article-title":"The efficacy of tradipitant in patients with diabetic and idiopathic gastroparesis in a phase 3 randomized placebo-controlled clinical trial","volume":"22","author":"Carlin","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib17","author":"Rohatgi"},{"key":"10.1053\/j.gastro.2025.08.004_bib18","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2025.08.004_bib19","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2025.08.004_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2025.08.004_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1053\/j.gastro.2025.08.004_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1503\/cmaj.060410","article-title":"The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey","volume":"176","author":"Ioannidis","year":"2007","journal-title":"CMAJ"},{"key":"10.1053\/j.gastro.2025.08.004_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1053\/j.gastro.2025.08.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R Package for Network Meta-Analysis Using Frequentist Methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J Stat Softw"},{"key":"10.1053\/j.gastro.2025.08.004_bib25","article-title":"mada: meta-analysis of diagnostic accuracy","author":"Doebler","year":"2022","journal-title":"R package version 0.5.11"},{"key":"10.1053\/j.gastro.2025.08.004_bib26","series-title":"R: A Language and Environment for Statistical Computing","year":"2024"},{"key":"10.1053\/j.gastro.2025.08.004_bib27","first-page":"478","article-title":"Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptying","volume":"58","author":"Ardila-Hani","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000175836","article-title":"Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy","volume":"78","author":"Cassilly","year":"2008","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2025.08.004_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14261","article-title":"Gastric half emptying time (T((1\/2))) for 4-h gastric emptying scintigraphy simplifies reporting but reduces detection of gastroparesis","volume":"34","author":"Gardella","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib30","first-page":"234","article-title":"Optimal timing of imaging in gastric emptying scintigraphy for the detection of delayed emptying","volume":"24","author":"Georgiou","year":"2021","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.gastro.2025.08.004_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1023\/A:1005697422454","article-title":"Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis","volume":"46","author":"Guo","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MNM.0b013e32835bd5da","article-title":"Comparison of criteria to truncate gastric emptying tests","volume":"34","author":"Nichols","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.gastro.2025.08.004_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MCG.0b013e31822f3ad2","article-title":"Gastric emptying scintigraphy: is four hours necessary?","volume":"46","author":"Pathikonda","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4274\/mirt.galenos.2021.65902","article-title":"Gastric emptying scintigraphy: diagnostic value of delayed imaging and the impact on reclassification of diagnosis","volume":"32","author":"Qutbi","year":"2023","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib35","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1053\/j.gastro.2019.01.249","article-title":"Effects of promotility agents on gastric emptying and symptoms: a systematic review and meta-analysis","volume":"156","author":"Vijayvargiya","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gutjnl-2018-316405","article-title":"Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis","volume":"68","author":"Vijayvargiya","year":"2019","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.08.004_bib37","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1572-0241.2000.02076.x","article-title":"Assessment of gastric emptying using a low fat meal: establishment of international control values","volume":"95","author":"Tougas","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib38","first-page":"G284","article-title":"Human gastric emptying and colonic filling of solids characterized by a new method","volume":"257","author":"Camilleri","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1053\/j.gastro.2025.08.004_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gutjnl-2020-322756","article-title":"Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial","volume":"71","author":"Vosoughi","year":"2022","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.08.004_bib40","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1053\/j.gastro.2021.01.230","article-title":"Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features","volume":"160","author":"Pasricha","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib41","doi-asserted-by":"crossref","first-page":"1076.e562","DOI":"10.1111\/j.1365-2982.2012.01972.x","article-title":"Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants","volume":"24","author":"Camilleri","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1542-3565(03)00130-7","article-title":"Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms","volume":"1","author":"Bredenoord","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib43","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/ajg.2017.264","article-title":"Gastric motor dysfunction in patients with functional gastroduodenal symptoms","volume":"112","author":"Park","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib44","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1136\/gutjnl-2023-330733","article-title":"Optimal measurement of gastric emptying of solids in gastroparesis or functional dyspepsia: evidence to establish standard test","volume":"72","author":"Camilleri","year":"2023","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.08.004_bib45","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/apt.16304","article-title":"Randomised study: effects of the 5-HT(4) receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis","volume":"53","author":"Chedid","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2982.2009.01378.x","article-title":"Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation","volume":"22","author":"Manini","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1053\/j.gastro.2025.08.004_bib48","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/nmo.12054","article-title":"Comprehensive assessment of gastric emptying with a stable isotope breath test","volume":"25","author":"Bharucha","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib49","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1651-2227.2000.tb00408.x","article-title":"Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal","volume":"89","author":"Perri","year":"2000","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.gastro.2025.08.004_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2982.2010.01612.x","article-title":"Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies","volume":"23","author":"Rao","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib51","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3109\/00365521.2016.1157893","article-title":"Delayed gastric emptying does not normalize after gluten withdrawal in adult celiac disease","volume":"51","author":"Usai-Satta","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diacare.6.5.463","article-title":"A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis","volume":"6","author":"McCallum","year":"1983","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2025.08.004_bib53","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF01314461","article-title":"Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study","volume":"24","author":"Perkel","year":"1979","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib54","first-page":"231","article-title":"Metoclopramide therapy in fifty-five patients with delayed gastric emptying","volume":"74","author":"Perkel","year":"1980","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib55","doi-asserted-by":"crossref","first-page":"444","DOI":"10.7326\/0003-4819-96-4-444","article-title":"Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial","volume":"96","author":"Snape","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2025.08.004_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004836-198502000-00003","article-title":"Effect of metoclopramide in diabetic gastroparesis","volume":"7","author":"Ricci","year":"1985","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib57","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.cgh.2014.12.030","article-title":"Metoclopramide nasal spray reduces symptoms of gastroparesis in women, but not men, with diabetes: results of a phase 2B randomized study","volume":"13","author":"Parkman","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib58","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.cgh.2023.10.022","article-title":"Metoclopramide nasal spray in women with symptomatic diabetic gastroparesis: a randomized, double-blind, placebo-controlled phase 3 study","volume":"22","author":"McCallum","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib59","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2147\/NDT.S328301","article-title":"Tardive dyskinesia in older persons taking antipsychotics","volume":"17","author":"Citrome","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1053\/j.gastro.2025.08.004_bib60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/bmj.288.6416.545","article-title":"Tardive dyskinesia associated with metoclopramide","volume":"288","author":"Wiholm","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.gastro.2025.08.004_bib61","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/bmj.291.6500.930","article-title":"Extrapyramidal reactions with metoclopramide","volume":"291","author":"Bateman","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.gastro.2025.08.004_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13617","article-title":"Gastroparesis, metoclopramide, and tardive dyskinesia: risk revisited","volume":"31","author":"Al-Saffar","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib63","doi-asserted-by":"crossref","first-page":"S-1466","DOI":"10.1016\/S0016-5085(25)04263-5","article-title":"Tu1698: comparison of the incidence of tardive dyskinesia in patients receiving continuous vs intermittent oral metoclopramide","volume":"169","author":"Russo","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib64","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/diacare.16.11.1511","article-title":"Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis","volume":"16","author":"Erbas","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2025.08.004_bib66","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10620-022-07698-z","article-title":"Erythromycin Improves the quality of esophagogastroduodenoscopy in upper gastrointestinal bleeding: a network meta-analysis","volume":"68","author":"Aziz","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib67","first-page":"193","article-title":"Erythromycin accelerates gastric emptying of indigestible solids and transpyloric migration of the tip of an enteral feeding tube in fasting and fed states","volume":"88","author":"Keshavarzian","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib68","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/jpet.104.081497","article-title":"Desensitization of the human motilin receptor by motilides","volume":"313","author":"Thielemans","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5056\/jnm.2010.16.4.407","article-title":"Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis","volume":"16","author":"Larson","year":"2010","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib70","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/BF01535938","article-title":"Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study","volume":"33","author":"Davis","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib71","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0149-2918(98)80054-4","article-title":"Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group","volume":"20","author":"Silvers","year":"1998","journal-title":"Clin Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib72","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/diacare.21.10.1699","article-title":"Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis","volume":"21","author":"Farup","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2025.08.004_bib73","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1111\/bcp.14737","article-title":"Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: a systematic review and meta-analysis of observational studies","volume":"87","author":"Ou","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2025.08.004_bib74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1464-5491.1985.tb00689.x","article-title":"Treatment of diabetic gastroparesis with oral domperidone","volume":"2","author":"Watts","year":"1985","journal-title":"Diabet Med"},{"key":"10.1053\/j.gastro.2025.08.004_bib75","first-page":"214","article-title":"Diabetic gastroparesis: treatment with domperidone\u2014a double-blind, placebo-controlled trial","volume":"27","author":"Heer","year":"1983","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2025.08.004_bib76","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1093\/jcag\/gwaa041","article-title":"Cardiovascular safety of metoclopramide compared to domperidone: a population-based cohort study","volume":"4","author":"Cowan","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib77","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.14309\/ajg.0000000000000304","article-title":"Prucalopride in gastroparesis: a randomized placebo-controlled crossover study","volume":"114","author":"Carbone","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13958","article-title":"Prucalopride in diabetic and connective tissue disease-related gastroparesis: randomized placebo-controlled crossover pilot trial","volume":"33","author":"Andrews","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib79","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2006.00865.x","article-title":"Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans","volume":"19","author":"Camilleri","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib80","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40360-025-00858-7","article-title":"An exploratory study evaluating the 20 medications most commonly associated with suicidal ideation and self-injurious behavior in the FAERS database","volume":"26","author":"Xie","year":"2025","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1053\/j.gastro.2025.08.004_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40272-023-00612-8","article-title":"Safety and effectiveness of prucalopride in children with functional constipation with and without upper symptoms","volume":"26","author":"Velez","year":"2024","journal-title":"Paediatr Drugs"},{"key":"10.1053\/j.gastro.2025.08.004_bib82","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jcpt.12087","article-title":"Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms","volume":"38","author":"Carnovale","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2017.08.033","article-title":"Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders","volume":"154","author":"Pasricha","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2020.07.029","article-title":"Efficacy and safety of tradipitant in patients with diabetic and idiopathic gastroparesis in a randomized, placebo-controlled trial","volume":"160","author":"Carlin","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib85","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2147\/DDDT.S125743","article-title":"Mirtazapine for symptom control in refractory gastroparesis","volume":"11","author":"Malamood","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib86","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1001\/jama.2013.282833","article-title":"Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial","volume":"310","author":"Parkman","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2025.08.004_bib87","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.08.004_bib88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.04.020","article-title":"Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study","volume":"149","author":"Talley","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib89","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2982.2007.01029.x","article-title":"The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial","volume":"20","author":"Choung","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib90","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/apt.17479","article-title":"Buspirone for early satiety and symptoms of gastroparesis: a multi-centre, randomised, placebo-controlled, double-masked trial (BESST)","volume":"57","author":"Parkman","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib91","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.cgh.2023.07.008","article-title":"A randomized, controlled trial of efficacy and safety of cannabidiol in idiopathic and diabetic gastroparesis","volume":"21","author":"Zheng","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib92","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/15563650.2020.1736298","article-title":"Does cannabidiol induce cannabinoid hyperemesis syndrome?","volume":"58","author":"Laborde-Casterot","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.gastro.2025.08.004_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ADM.0000000000001378","article-title":"Cannabinoid hyperemesis syndrome presumed secondary to CBD use: a case report","volume":"19","author":"Lefebvre","year":"2025","journal-title":"J Addict Med"},{"key":"10.1053\/j.gastro.2025.08.004_bib94","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s11605-019-04294-x","article-title":"Treatment utilization and socioeconomic disparities in the surgical management of gastroparesis","volume":"24","author":"Gray","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.gastro.2025.08.004_bib95","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2036.2007.03467.x","article-title":"Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis","volume":"26","author":"Arts","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.08.004_bib96","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1572-0241.2007.01676.x","article-title":"Botulinum toxin A for the treatment of delayed gastric emptying","volume":"103","author":"Friedenberg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib97","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/a-2235-3286","article-title":"Gastric peroral endoscopic myotomy versus botulinum toxin injection for the treatment of refractory gastroparesis: results of a double-blind randomized controlled study","volume":"56","author":"Gonzalez","year":"2024","journal-title":"Endoscopy"},{"key":"10.1053\/j.gastro.2025.08.004_bib98","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1136\/gutjnl-2022-326904","article-title":"Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial","volume":"71","author":"Martinek","year":"2022","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.08.004_bib99","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.gie.2019.04.228","article-title":"Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection","volume":"90","author":"Desprez","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2025.08.004_bib100","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s10620-018-4976-9","article-title":"Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience","volume":"63","author":"Malik","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib101","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.14309\/ajg.0000000000003213","article-title":"Predictors of outcomes after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review","volume":"120","author":"Varghese","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.004_bib102","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1055\/a-1986-4292","article-title":"Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis","volume":"55","author":"Wadhwa","year":"2023","journal-title":"Endoscopy"},{"key":"10.1053\/j.gastro.2025.08.004_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13892","article-title":"Impact of gastric per-oral endoscopic myotomy on static and dynamic pyloric function in gastroparesis patients","volume":"32","author":"Watts","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib104","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s10620-008-0660-9","article-title":"Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients","volume":"54","author":"Coleski","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/a-0628-6639","article-title":"Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function","volume":"51","author":"Jacques","year":"2019","journal-title":"Endoscopy"},{"key":"10.1053\/j.gastro.2025.08.004_bib106","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MAJ.0b013e318182ee33","article-title":"Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis","volume":"337","author":"Reddymasu","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.gastro.2025.08.004_bib107","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1089\/lap.2017.0099","article-title":"Pyloroplasty offers relief of postfundoplication gastroparesis in patients who improved after botulinum toxin injection","volume":"27","author":"Gilsdorf","year":"2017","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"10.1053\/j.gastro.2025.08.004_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14565","article-title":"Gastric electrical stimulation versus per-oral pyloromyotomy for the treatment of nausea and vomiting associated with gastroparesis: an observational study of two cohorts","volume":"35","author":"Gourcerol","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib109","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/a-1111-8566","article-title":"Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis: a propensity score-matched analysis of long term outcomes","volume":"52","author":"Shen","year":"2020","journal-title":"Endoscopy"},{"key":"10.1053\/j.gastro.2025.08.004_bib110","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1111\/jgh.15599","article-title":"Gastric per-oral endoscopic myotomy versus pyloromyotomy for gastroparesis: an international comparative study","volume":"36","author":"Pioppo","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib111","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s00464-022-09437-x","article-title":"[S156] Comparing outcomes of per-oral pyloromyotomy and robotic pyloroplasty for the treatment of gastroparesis","volume":"37","author":"Clapp","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1053\/j.gastro.2025.08.004_bib112","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.gie.2023.04.2079","article-title":"Gastric peroral endoscopic myotomy for management of refractory gastroparesis in patients with gastric neurostimulator devices: a multicenter retrospective case control study","volume":"98","author":"Ichkhanian","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2025.08.004_bib113","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.gassur.2024.08.007","article-title":"Efficacy of gastric stimulator as an adjunct to pyloroplasty for gastroparesis: characterizing patients suitable for single procedure vs dual procedure approach","volume":"28","author":"Eriksson","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.gastro.2025.08.004_bib114","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s11605-019-04391-x","article-title":"Surgical treatment for refractory gastroparesis: stimulator, pyloric surgery, or both?","volume":"24","author":"Zoll","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.gastro.2025.08.004_bib115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11605-016-3327-4","article-title":"The long-term efficacy and safety of pyloroplasty combined with gastric electrical stimulation therapy in gastroparesis","volume":"21","author":"Davis","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.gastro.2025.08.004_bib116","doi-asserted-by":"crossref","first-page":"134.e80","DOI":"10.1111\/nmo.12032","article-title":"The addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesis","volume":"25","author":"Sarosiek","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib117","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0016-5085(03)00878-3","article-title":"Gastric electrical stimulation for medically refractory gastroparesis","volume":"125","author":"Abell","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib118","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cgh.2010.05.020","article-title":"Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study","volume":"8","author":"McCallum","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.004_bib119","doi-asserted-by":"crossref","first-page":"815.e636","DOI":"10.1111\/nmo.12185","article-title":"Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis","volume":"25","author":"McCallum","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.gastro.2019.10.018","article-title":"Gastric electrical stimulation reduces refractory vomiting in a randomized crossover trial","volume":"158","author":"Ducrotte","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.004_bib121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2982.2009.01389.x","article-title":"Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients","volume":"22","author":"McCallum","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2025.08.004_bib122","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/XCS.0000000000001105","article-title":"Clinical outcomes of a large, prospective series of gastric electrical stimulation patients using a multidisciplinary protocol","volume":"239","author":"Cassidy","year":"2024","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.gastro.2025.08.004_bib123","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.gie.2011.05.022","article-title":"A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis","volume":"74","author":"Abell","year":"2011","journal-title":"Gastrointest Endosc"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525058573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525058573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:21:57Z","timestamp":1778473317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525058573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0016508525058573"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.08.004","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Guideline on Management of Gastroparesis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}